Vestal Point Capital, LP

Q2 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
68
Total value ($000)
$4,279,458
Net value change ($000)
+702,641 (19.6%)
New positions
11
Sold out positions
33
Turnover %
27.8%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
UTHR 191,222 430.0%
NBIX 152,171 92.4%
ABVX 146,062 87.4%
BMRN 142,799 70.7%
ABT 127,036 NEW
ZBH 103,346 601.5%
Ascendis Pharma AS 100,020 NEW
NRIX 94,543 93.8%
PODD 91,390 860.7%
ELVN 75,600 59.3%
Top Reduces (Value $000, Stocks/ETFs)
RVMD -146,693 -63.5%
APGE -92,587 -100.0%
ASND -85,774 -100.0%
SRRK -65,109 -100.0%
VERA -55,041 -100.0%
RGEN -54,408 -49.9%
TERN -52,720 -100.0%
BSX -50,200 -100.0%
NUVL -49,352 -100.0%
COGT -47,377 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type